P2Y12 inhibitors linked to lower rates of cardiovascular events compared to aspirin
Giving a P2Y12 inhibitor anti-clotting drug to patients with coronary artery disease is associated with lower rates of cardiovascular death, heart attack and stroke compared with traditional aspirin, with no…